Quantcast

Latest Genentech Stories

2014-03-12 12:29:13

Surveyed U.S. Payers Look for Substantial Delivery Achievements for Inclusion of New Agents in Formularies, According to Findings from Decision Resources Group BURLINGTON, Mass., March 12, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and European retinal specialists ascribe a moderate to high unmet need for wet age-related macular degeneration (AMD) therapies that improve visual acuity. In line with this finding, surveyed U.S. retinal specialists expect that they...

2014-03-11 16:26:30

INCLINE VILLAGE, Nev., March 11, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the first quarter ending March 31, 2014, of approximately $133 million, as compared with actual revenue of $91.8 million for the first quarter of 2013, an approximate 45 percent increase. The forecasted growth in revenues is driven by increased fourth quarter 2013 sales for Avastin(®), Herceptin(®), Xolair(®), Kadcyla(®), Perjeta(®), and...

2014-03-03 16:25:50

- Annual Revenues Increased 18 Percent during 2013 - INCLINE VILLAGE, Nev., March 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2013. http://photos.prnewswire.com/prnvar/20110822/SF55808LOGO Total revenues in 2013 increased 18 percent to $442.9 million from $374.5 million in 2012. For the fourth quarter of 2013, total revenues were $110.1 million, compared to $86.0 million in...

2014-02-25 08:33:25

MOUNTAIN VIEW, Calif., Feb. 25, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Robert A. Lippe has joined the Company as Executive Vice President, Operations and Chief Operations Officer. In this newly created position, Mr. Lippe has responsibility for the Company's global operation functions, including strategic development and execution of clinical and commercial manufacturing, quality and compliance, supply chain and supply partner...

2014-02-24 08:29:54

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Ambrx Inc. today announced that Sheila Gujrathi, M.D., has joined its board of directors. Dr. Gujrathi is currently the chief medical officer at Receptos (Nasdaq: RCPT) where she is responsible for the clinical development of therapeutic candidates for the treatment of immune and metabolic diseases. "Sheila is an industry veteran with significant experience in immunologic and oncologic drug development," said Lawson Macartney, Ph.D., chief...

2014-02-20 08:32:32

LA JOLLA, Calif., Feb. 20, 2014 /PRNewswire/ -- Cultivated mammalian cells, known as "mammalian fermentation," have become the dominant system for the production of recombinant proteins for clinical applications. To bring these products to market involves significant effort and continuous advances in process development. These efforts aim to increase the level of product understanding and identify those key quality attributes that help in reproducing product batches. (Photo:...

2014-02-15 23:00:09

ChinaMarketResearchReports.com adds Latest Reports on Atorvastatin and Trastuzumab industry for China to its store. Dallas, TX (PRWEB) February 16, 2014 The prevalence rate of abnormal blood lipid in China is lower than that in most developed countries, but the average serum TC level of Chinese people is upgrading for the economic development and lifestyle change. Meanwhile, diabetes and metabolic syndromes are very common in China. According to statistics, the prevalence rate of abnormal...

2014-02-03 08:27:04

INCLINE VILLAGE, Nev., Feb. 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd. (Roche) which resolves all outstanding legal disputes between the parties, including its Nevada litigation with Genentech and Roche and its arbitration proceedings with Genentech related to the audit of royalties on sales. (Logo:...

2014-01-14 12:26:37

PASADENA, Calif., Jan. 14, 2014 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing antibody-based products, today announced the appointment of inaugural members of its newly-formed scientific advisory board. The board will leverage its extensive experience in protein engineering to advise the company to help advance its proprietary monoclonal antibody (mAb) technology platform for the development of novel antibody-drug conjugates. "We are very proud to appoint...

2014-01-07 08:31:00

Lam Joins KaloBios with Over 28 Years Biopharmaceutical Manufacturing Experience SOUTH SAN FRANCISCO, Calif., Jan. 7, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Harry Lam, Ph.D. as Head of Manufacturing. Dr. Lam brings to KaloBios more than 28 years of experience in biopharmaceutical manufacturing, including 17 years at Genentech, where he ultimately served as Global Head of Contract Manufacturing Operations, Commercial Drug...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.